AstraZeneca to deliver vaccine trial data by year's end
LONDON (AP) — AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
